β-Lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 2, 1996, Pages 460-463

  Fournier, Bénédicte ^a,b   Lagrange, Philippe H ^a   Philippon, Alain ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAM; BETA LACTAMASE;

ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; GENE MUTATION; GENE SEQUENCE; KLEBSIELLA OXYTOCA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0030052433     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.2.460     Document Type: Article

References (16)

1. Ankaru, Y. 1967. The reduction and restoration of galactose transport in osmotically shocked cells of Escherichia coli. J. Biol. Chem. 242:793-800
2. Arakawa, Y., M. Ohta, N. Kido, M. Mori, H. Ito, T. Komatsu, Y. Fujii, and N. Kato. 1989 Chromosomal β-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum β-lactam antibiotics. Antimicrob. Agents Chemother 33:63-70.
3. Buirma, R. J. A., A. M. Morrevorts, and J. H. T. Wagenvoort. 1991. Incidence of multi-resistant gram-negative isolates in eight Dutch hospitals Scand. J. Infect. Dis. 78(Suppl.):35-44.
4. Comité OMS d'Experts de la Standardisation Biologique. 1977 28e rapport, p 106-138. In Serie de rapports techniques no 610. Organisation Mondiale de la Santé, Geneva
5. Fournier, B., G. Arlet, P. H. Lagrange, and A. Philippon. 1994 Klebsiella oxytoca, resistance to aztreonam by overproduction of the chromosomally encoded β-lactamase. FEMS Microbiol. Lett 116:31-36.
6. Fournier, B., C. Y. Lu, P. H. Lagrange, R. Krishnamoorthy, and A. Philippon. 1995 Point mutation in the Pribnow box, the molecular basis of β-lactamase overproduction in Klebsiella oxytoca. Antimicrob. Agents Chemother. 39:1365-1368.
7. OXY-2. Antimicrob Agents Chemother. 40:454-459.
8. Hawley, D., and W. R. McClure. 1983. Compilation and analysis of Escherichia coli promoter DNA sequences. Nucleic Acids Res. 11:2237-2255.
9. Jaurin, B., T. Grundström, and S. Normark. 1982. Sequence elements determining ampC promoter strength in Escherichia coli. EMBO J. 1:875-881.
10. Kobayashi, M., K. Nagata, and A. Ishihama. 1990 Promoter selectivity of Escherichia coli RNA polymerase: effect of base substitutions in the promoter -35 region on promoter strength. Nucleic Acids Res. 18:7367-7372.
11. Livermore, D. M. 1995 β-Lactamases in laboratory and clinical resistance. Clin. Microbiol Rev. 8:557-584.
12. Monnet, D., and J. Freney. 1994. Method for differentiating Klebsiella planticola and Kiebsiella terrigena from other Klebsiella species. J. Clin. Microbiol. 32:1121-1122.
13. Paul, G, M. Barthélémy, A. Philippon, J. Peduzzi, L. Gilly, R. Labia, and P. Névot. 1988. Immunological comparison of constitutive β-lactamases of Gram-negative bacteria by neutralization in zymogram gels properties of anti-TEM-1 and anti-TEM-2 sera. Ann. Inst. Pasteur/Microbiol. (Paris) 139: 435-451.
14. Shah, P. M., R. Asanger, and M. Kahan. 1991. Incidence of multi-resistance in gram-negative aerobes from intensive care units of 10 German hospitals. Scand. J. Infect. Dis. 78(Suppl):22-34.
15. Sirol, D. L., F. W. Goldstein, C. J. Soussy, A. L. Courtieu, M. O. Husson, J. Lemozy, M. Meyran, C. Morel, R. Perez, C. Quentin-Noury, M. E. Reverdy, J. M. Scheftel, M. Rosembaum, and Y. Rezvani. 1992. Resistance to cefotaxime and seven other β-lactams in members of the family Enterobacteriaceae: a 3-year survey in France Antimicrob Agents Chemother. 36:1677-1681.
16. Snydman, D. R. 1991 Clinical implications of multi-drug resistance in the intensive care unit. Scand. J Infect. Dis 78(Suppl.):54-63.